Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Senior Principal Scientist at Roche Innovation Center Basel, Switzerland
Dr. Andreas Dieckmann is a Senior Principal Scientist at F. Hoffmann La Roche Ltd. focusing on safety assessments of antisense oligonucleotides. Andreas obtained his PhD in Molecular Biology from the University of Bochum (Germany) and continued his scientific career as Postdoc at the German Cancer Research Centre in Heidelberg and as Junior Group Leader at the Karolinska Institute. He joined Roche in 2013 from Takeda Pharmaceuticals International GmbH (Zurich) where he held the position of Fellow Experimental Medicine Biomarker Development. Prior to this position, Andreas worked as a Senior Biomarker Specialist at Nycomed (Konstanz, Germany). His previous experience before joining Nycomed included a position as Head of Preclinical Development at Novosom AG (Halle/Saale, Germany), Group Leader at InDex Pharmaceuticals AB (Stockholm), and Scientist in the gene expression department at GPC Biotech AG (Munich).